BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19513525)

  • 1. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
    Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
    Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
    Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.
    Opstal-van Winden AW; Krop EJ; Kåredal MH; Gast MC; Lindh CH; Jeppsson MC; Jönsson BA; Grobbee DE; Peeters PH; Beijnen JH; van Gils CH; Vermeulen RC
    BMC Cancer; 2011 Aug; 11():381. PubMed ID: 21871081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and identification of potential biomarkers of breast cancer.
    Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.
    Gast MC; Zapatka M; van Tinteren H; Bontenbal M; Span PN; Tjan-Heijnen VC; Knol JC; Jimenez CR; Schellens JH; Beijnen JH
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1773-83. PubMed ID: 21913038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.
    Gast MC; van Dulken EJ; van Loenen TK; Kingma-Vegter F; Westerga J; Flohil CC; Knol JC; Jimenez CR; van Gils CH; Wessels LF; Schellens JH; Beijnen JH
    Int J Biol Markers; 2009; 24(3):130-41. PubMed ID: 19787623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 17-protein signature in the serum of lung cancer patients.
    Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
    Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
    Belluco C; Petricoin EF; Mammano E; Facchiano F; Ross-Rucker S; Nitti D; Di Maggio C; Liu C; Lise M; Liotta LA; Whiteley G
    Ann Surg Oncol; 2007 Sep; 14(9):2470-6. PubMed ID: 17594124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnostic protein biomarkers for breast cancer: how far have we come?
    Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
    Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study.
    van Winden AW; Gast MC; Beijnen JH; Rutgers EJ; Grobbee DE; Peeters PH; van Gils CH
    BMC Med Genomics; 2009 Jan; 2():4. PubMed ID: 19152674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
    Cazares LH; Diaz JI; Drake RR; Semmes OJ
    Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.